2020-10-29 OMA Agenda - Board of Trustees

Table 1. Summary of professional healthcare society guidelines on caring for patients with obesity published within the last ten years. Professional healthcare society author or endorsement Year published Document type Primary topic Key points or recommendations US Preventive Services Task Force 7 2018 Recommendation statement Screening and referral for patients with obesity

Clinicians offer or refer adults with a BMI ≥30 kg/m 2 to intensive, multicomponent behavioral interventions.

The Obesity Society 6

2018

Position statement Obesity as a disease Confirmation of the society’s stance that obesity is a chronic disease.

American Academy of Family Physicians

2013

Monograph

Screening, treatment and referral for patients with obesity

Screen all adults for obesity. Offer or refer patients with a BMI ≥30 kg/m 2 to intensive, multicomponent behavioral interventions. Consider pharmacotherapy in adults who have not been able to lose weight through diet and physical activity alone and who have BMI ≥30 kg/m 2 or BMI ≥27 kg/m 2 and obesity- related comorbidity. Consider bariatric surgery in adults who have not been able to lose weight through diet and physical activity alone and who have BMI ≥40 kg/m 2 or BMI ≥35 kg/m 2 and obesity- related comorbidity. Regardless of body weight or weight loss, all patients should be encouraged to be physically active for improved health and weight maintenance. Diet, exercise, and behavioral modification should be included in all obesity management approaches for BMI ≥25 kg/m 2 and that other tools such as pharmacotherapy (BMI ≥27 kg/m 2 with comorbidity or BMI >30 kg/m 2 ) and bar iatric surgery (BMI ≥35 kg/m 2 with comorbidity or BMI >40 kg/m 2 ) be used as adjuncts to behavioral modification Use approved weight loss medication (over no pharmacological therapy) to promote weight maintenance

Endocrine Society 8

2015

Clinical Practice Guideline

Pharmacotherapy for obesity

26